Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Quinn

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|November 3, 2012
Rheumatoid arthritis classification criteria: moving with the timesMark A Quinn
Rheumatic Diseases Clinics of North America|November 17, 2005
Potential for altering rheumatoid arthritis outcomeMark A Quinn, Paul Emery
Best Practice & Research. Clinical Rheumatology|December 14, 2004
Are early arthritis clinics necessary?Mark A Quinn, Paul Emery
Rheumatic Diseases Clinics of North America|November 17, 2005
The evidence for early interventionMark A Quinn, Sally Cox
Rheumatology (Oxford, England)|July 3, 2010
Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritisVictoria Bejarano, Philip G Conaghan, Mark A Quinn, et al.
International Journal of Rheumatology|November 5, 2010
Successful Treatment of ANCA-Negative Wegener's Granulomatosis with RituximabAfsha Khan, Catherine A Lawson, Mark A Quinn, et al.
Arthritis and Rheumatism|July 19, 2002
Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?Philip G Conaghan, Mark A Quinn, Philip O'Connor, et al.
Arthritis and Rheumatism|December 1, 2007
Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritisRichard J Wakefield, Jane E Freeston, Elizabeth M A Hensor, et al.
The Journal of Rheumatology|October 7, 2003
Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case seriesStephen J Jarrett, Gaye Cunnane, Philip G Conaghan, et al.
Arthritis and Rheumatism|November 13, 2003
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocolMark A Quinn, Michael J Green, Helena Marzo-Ortega, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|November 3, 2012
Rheumatoid arthritis classification criteria: moving with the timesMark A Quinn
Rheumatic Diseases Clinics of North America|November 17, 2005
Potential for altering rheumatoid arthritis outcomeMark A Quinn, Paul Emery
Best Practice & Research. Clinical Rheumatology|December 14, 2004
Are early arthritis clinics necessary?Mark A Quinn, Paul Emery
Rheumatic Diseases Clinics of North America|November 17, 2005
The evidence for early interventionMark A Quinn, Sally Cox
Rheumatology (Oxford, England)|July 3, 2010
Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritisVictoria Bejarano, Philip G Conaghan, Mark A Quinn, et al.
International Journal of Rheumatology|November 5, 2010
Successful Treatment of ANCA-Negative Wegener's Granulomatosis with RituximabAfsha Khan, Catherine A Lawson, Mark A Quinn, et al.
Arthritis and Rheumatism|July 19, 2002
Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?Philip G Conaghan, Mark A Quinn, Philip O'Connor, et al.
Arthritis and Rheumatism|December 1, 2007
Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritisRichard J Wakefield, Jane E Freeston, Elizabeth M A Hensor, et al.
The Journal of Rheumatology|October 7, 2003
Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case seriesStephen J Jarrett, Gaye Cunnane, Philip G Conaghan, et al.
Arthritis and Rheumatism|November 13, 2003
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocolMark A Quinn, Michael J Green, Helena Marzo-Ortega, et al.
Pageof 2